Treatment for eye redness in dry eye disease
Part of Eyes & vision clinical trials.
This study tests a new eye drop that aims to reduce redness in people with dry eye disease. It may help if you have dry eyes and noticeable redness.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with dry eye disease.
- You have redness in both eyes.
- You do not have an eye infection or allergic conjunctivitis.
- You do not have any other active eye disease.
- You must not wear contact lenses during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new eye drop solution (PRO-240) compared to an existing one (Optive) in healthy adults. It aims to see how safe and comfortable the new drops are for dry eye relief.
This trial compares two different dry-eye eye drops to see which works better and is safe. You may be able to join if you’ve had dry eye for at least 3 months and meet specific eye-test results.
This study tests an eye drop made from human platelets (the cells that help healing) to see if it reduces dry eye symptoms better than a placebo. It is for people with moderate to severe dry eye.
This study tests an experimental eye drop to see if it reduces eye redness better than a placebo (inactive) drop. If you often have red eyes and want a new option, this may be a good fit.
This study tests a new eye drop called FID 123472 to see how well it reduces redness in adults. If you have persistent eye redness and have used redness relief drops before, this trial might help you find a longer-lasting solution.
This study tests an experimental eye drop for people with dry eye disease. It aims to see if the drops can reduce symptoms and signs of dry eye.
Hear when a new Dry Eye Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.